These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7660146

  • 1. Anticoagulant actions of tissue factor pathway inhibitor on tissue-factor-dependent plasma coagulation.
    Ofosu FA.
    Semin Thromb Hemost; 1995; 21(2):240-4. PubMed ID: 7660146
    [Abstract] [Full Text] [Related]

  • 2. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N.
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [Abstract] [Full Text] [Related]

  • 3. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O, Kristensen HI, Valentin S, Ostergaard P, Wadt J.
    Thromb Haemost; 1993 Sep 01; 70(3):448-53. PubMed ID: 8259547
    [Abstract] [Full Text] [Related]

  • 4. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C, Mann KG.
    J Biol Chem; 1997 Feb 14; 272(7):4367-77. PubMed ID: 9020158
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T, Franssen J, Willems G.
    Thromb Haemost; 1995 Sep 14; 74(3):910-5. PubMed ID: 8571320
    [Abstract] [Full Text] [Related]

  • 6. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
    Nagase H, Enjyoji K, Kamikubo Y, Kitazato KT, Kitazato K, Saito H, Kato H.
    Thromb Haemost; 1997 Aug 14; 78(2):864-70. PubMed ID: 9268186
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.
    Valentin S, Reutlingsperger CP, Nordfang O, Lindhout T.
    Thromb Haemost; 1995 Dec 14; 74(6):1478-85. PubMed ID: 8772224
    [Abstract] [Full Text] [Related]

  • 8. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.
    Salemink I, Franssen J, Willems GM, Hemker HC, Li A, Wun TC, Lindhout T.
    Thromb Haemost; 1998 Aug 14; 80(2):273-80. PubMed ID: 9716152
    [Abstract] [Full Text] [Related]

  • 9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B, Griffin JH.
    Clin Haematol; 1985 Jun 14; 14(2):281-342. PubMed ID: 2994929
    [Abstract] [Full Text] [Related]

  • 10. The importance of the binding of factor Xa to phospholipids in the inhibitory mechanism of tissue factor pathway inhibitor: the transmembrane and cytoplasmic domains of tissue factor are not essential for the inhibitory action of tissue factor pathway inhibitor.
    Kazama Y.
    Thromb Haemost; 1997 Mar 14; 77(3):492-7. PubMed ID: 9066000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Control mechanisms in thrombin generation.
    Ofosu FA, Liu L, Freedman J.
    Semin Thromb Hemost; 1996 Mar 14; 22(4):303-8. PubMed ID: 8944414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A, Ruf W, Rao LV.
    Thromb Haemost; 2001 Mar 14; 85(3):458-63. PubMed ID: 11307815
    [Abstract] [Full Text] [Related]

  • 17. Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.
    Okwusidi JI, Anvari N, Ofosu FA.
    J Lab Clin Med; 1993 Jan 14; 121(1):64-70. PubMed ID: 8426082
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 Jan 14; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 19. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
    Mast AE, Broze GJ.
    Blood; 1996 Mar 01; 87(5):1845-50. PubMed ID: 8634431
    [Abstract] [Full Text] [Related]

  • 20. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H, Enjyoji K, Minamiguchi K, Kitazato KT, Kitazato K, Saito H, Kato H.
    Blood; 1995 Mar 15; 85(6):1527-34. PubMed ID: 7888673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.